R Chatelain
Overview
Explore the profile of R Chatelain including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
69
Citations
439
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Werner S, Langer H, Chatelain R
Rheuma Plus
. 2021 Nov;
20(6):267-271.
PMID: 34745375
Since the first case of coronavirus infection with SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) and the associated COVID-19 (corona virus disease 2019) it has become a worldwide pandemic. This...
2.
Stretz E, Oppel E, Rawer H, Chatelain R, Mastnik S, Przybilla B, et al.
Clin Exp Allergy
. 2017 Aug;
47(12):1631-1639.
PMID: 28802075
Background: An omalizumab treatment and a high maintenance venom dose may both help to prevent recurrent systemic allergic reactions (SAR) to venom immunotherapy (VIT). The effectiveness of this combination therapy,...
3.
Krishna S, Murray C, McInnes M, Chatelain R, Siddaiah M, Al-Dandan O, et al.
Clin Radiol
. 2017 Jun;
72(9):708-721.
PMID: 28592361
Computed tomography (CT) remains the first-line imaging test for the characterisation of renal masses; however, CT has inherent limitations, which if unrecognised, may result in errors. The purpose of this...
4.
Rueff F, Vos B, Oude Elberink J, Bender A, Chatelain R, Dugas-Breit S, et al.
Clin Exp Allergy
. 2014 Jan;
44(5):736-46.
PMID: 24447114
Background: Treatment failure during venom immunotherapy (VIT) may be associated with a variety of risk factors, of which the relative importance is unknown. Objective: Our aim was to evaluate the...
5.
Bell S, Kuntze I, Caputo A, Chatelain R
Food Chem Toxicol
. 2001 Dec;
40(1):19-24.
PMID: 11731032
The toxic oil syndrome is an exogenously-induced autoimmune disease in humans, which is believed to be due to the accidental ingestion of oleic acid anilides. In a previously established murine...
6.
Bell S, Sander C, Kuntze I, Chatelain R
Arch Toxicol
. 2000 Jan;
73(8-9):493-5.
PMID: 10650923
Two groups of compounds, the fatty acid anilides and the mono- and diester of 3-phenylamino-1,2-propanediol (PAP) are suspected as aetiologic agents for the toxic oil syndrome (TOS). Intraperitoneal administration of...
7.
Chatelain R, Mauze S, Varkila K, Coffman R
Parasite Immunol
. 1999 Jul;
21(8):423-31.
PMID: 10417676
The outcome of experimental Leishmania major infection in mice is closely correlated with the type of CD4+ helper T cell (Th) response. Whereas a Th1 response is host protective, a...
8.
Chatelain R, Mauze S, Coffman R
Parasite Immunol
. 1999 May;
21(4):211-8.
PMID: 10320618
L. major infection of mice induces polarized Th1 and Th2 responses that are correlated with healing of the infection (Th1) or a fatal disease (Th2). The Th subset specific cytokines,...
9.
Chatelain R, Wollenberg A, Martin C, Bieber T, Degitz K, Heckmann M
Arch Dermatol Res
. 1998 Nov;
290(9):477-82.
PMID: 9808340
Intercellular adhesion molecule-1 (ICAM-1) is regularly expressed or inducible on all major cutaneous cell populations including Langerhans cells, keratinocytes, endothelial cells and dermal fibroblasts. ICAM-1 is induced in the skin...
10.
Chatelain R, Bell S, Konz B, Rocken M
Hautarzt
. 1998 Jul;
49(6):496-8.
PMID: 9675579
A 53 year old man presented with a giant variant of granuloma faciale, closely resembling rhinophyma. Therapeutic approaches with cryosurgery and dapsone were unsuccessful. Surgical reconstruction of the nasal skin...